[Case report of advanced esophageal cancer patient surviving for a long time after asynchronous chemoradiation].
We have present a case of advanced esophageal cancer(Stage IVb), that has survived for 7 years and 4 months after systemic hemotherapy followed by radiation therapy. The patient is a female, 63 years old. We diagnosed her with esophageal cancer Stage IVb with direct invasion to the main bronchus and the metastatic lesion to the right lobe of thyroid gland. Then we initiated low-dose FP therapy(5-FU 500 mg/day/body, day 1-7, CDDP 10 mg/day/body day 1-5), and then continued UFT+CDDP(UFT 400 mg/day, CDDP 10 mg/day). About 4 years and eight months after chemotherapy we detected swelling of a mediastinal lymph node, which was assessed as a recurrence. Then we started the radiation therapy. Since she has received UFT, we have not seen any recurrences.
Okamura
Shigeki
S
Dept. of General Surgery, Health Insurance Hitoyoshi General Hospital, Japan.
Kimura
Masami
M
Kawata
Kousei
K
Hirata
Takafumi
T
Matsushita
Hiroo
H
Harada
Hiroaki
H
Nishimura
Takumasa
T
Shimokawa
Yasuhiro
Y
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D005260:Female; D005773:Gastroscopy; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D013997:Time Factors; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents